These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10231415)

  • 1. Loss of E-cadherin expression in early gastric cancer.
    Blok P; Craanen ME; Dekker W; Tytgat GN
    Histopathology; 1999 May; 34(5):410-5. PubMed ID: 10231415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of cyclin D1 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; van Diest PJ; Dekker W; Tytgat GN
    Histopathology; 2000 Feb; 36(2):151-5. PubMed ID: 10672060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for c-erbB-2 overexpression in gastric carcinogenesis.
    Blok P; Craanen ME; Dekker W; Offerhaus GJ; Tytgat GN
    Histopathology; 1998 Apr; 32(4):335-9. PubMed ID: 9602330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
    Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
    World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of e-cadherin and catenins in early gastric cancer.
    Joo YE; Rew JS; Choi SK; Bom HS; Park CS; Kim SJ
    J Clin Gastroenterol; 2002 Jul; 35(1):35-42. PubMed ID: 12080224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer].
    Guzmán P; Araya J; Villaseca M; Roa I; Melo A; Muñoz S; Roa J
    Rev Med Chil; 2006 Aug; 134(8):1002-9. PubMed ID: 17130988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of E-cadherin in gastric carcinoma and its correlation with lymph node micrometastasis.
    Wu ZY; Zhan WH; Li JH; He YL; Wang JP; Lan P; Peng JS; Cai SR
    World J Gastroenterol; 2005 May; 11(20):3139-43. PubMed ID: 15918205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer.
    Shun CT; Wu MS; Lin JT; Wang HP; Houng RL; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1998; 45(22):944-9. PubMed ID: 9755986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
    Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
    Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
    Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
    J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E-cadherin expression as a differentiation marker in gastric cancer.
    Karayiannakis AJ; Syrigos KN; Chatzigianni E; Papanikolaou S; Karatzas G
    Hepatogastroenterology; 1998; 45(24):2437-42. PubMed ID: 9951940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta.
    Song SY; Kim S; Kim DS; Son HJ; Rhee JC; Kim YI
    J Clin Gastroenterol; 2004 Mar; 38(3):252-9. PubMed ID: 15128072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
    Ramesh S; Nash J; McCulloch PG
    Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of a Li-cadherin in gastric cancer and intestinal metaplasia.
    Dong W; Yu Q; Xu Y
    Dig Dis Sci; 2007 Feb; 52(2):536-42. PubMed ID: 17226075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronology of p53 protein accumulation in gastric carcinogenesis.
    Craanen ME; Blok P; Dekker W; Offerhaus GJ; Tytgat GN
    Gut; 1995 Jun; 36(6):848-52. PubMed ID: 7615272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between lymph node metastasis and E-cadherin expression in submucosal invasive gastric carcinomas with gastric-phenotype.
    Aoki R; Yasuda M; Torisu R; Nakamoto J; Yamamoto Y; Ito S
    J Med Invest; 2007 Feb; 54(1-2):159-67. PubMed ID: 17380028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunohistochemical expression of E-cadherin in gastric cancer; correlations with clinicopathological factors and patients' survival.
    Lazăr D; Tăban S; Ardeleanu C; Dema A; Sporea I; Cornianu M; Lazăr E; Vernic C
    Rom J Morphol Embryol; 2008; 49(4):459-67. PubMed ID: 19050793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin in gastric carcinomas related to histological prognostic parameters.
    Stănculescu D; Mărgăritescu C; Stepan A; Mitruţ AO
    Rom J Morphol Embryol; 2011; 52(3 Suppl):1107-12. PubMed ID: 22119833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.
    Czyzewska J; Guzińska-Ustymowicz K; Ustymowicz M; Pryczynicz A; Kemona A
    Folia Histochem Cytobiol; 2010 Jan; 48(1):37-45. PubMed ID: 20529814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of expression of proliferating cell nuclear antigen and E-cadherin in gastric carcinoma.
    Hu L; Li HL; Li WF; Chen JM; Yang JT; Gu JJ; Xin L
    World J Gastroenterol; 2017 May; 23(20):3721-3729. PubMed ID: 28611525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.